NCARDIA

In News

Ncardia Launches First-of-Its-Kind iPSC-Derived Non-Human Primate Cardiomyocytes to Advance Cardiac Safety Research - BioSpace

BioSpace - Sep 24, 2025

Advancing the Future of Cardiac Safety - Fierce Biotech

Fierce Biotech - Sep 24, 2025

New platform to accelerate cardiac drug development - Universiteit Leiden

Universiteit Leiden - Jan 22, 2026

Ncardia Launches Cellistic™, the Only iPSC-based Cell Therapy Process Development & Manufacturing Partner Purpose-built to Make Large-scale Allogeneic Cell Therapy Production a Reality Today - BioInformant

BioInformant - Apr 26, 2022

iPSC technology company Ncardia receives US$60 million investment - RegMedNet

RegMedNet - Nov 17, 2021

Ncardia Launches Ncyte® Heart in a Box to Advance Cardiovascular Research and Precision Medicine - Business Wire

Business Wire - Jan 27, 2025

Ncardia Expands iPSC Manufacturing and Phenotypic Drug Discovery Services With Support From Investors - PR Newswire

PR Newswire - Jul 15, 2019

Ncardia inks $60M funding deal to expand discovery and commercial production services for stem cells - Fierce Biotech

Fierce Biotech - Nov 16, 2021

NCardia, a Global Force in hiPSC Drug Discovery and Development Products and Solutions - BioInformant

BioInformant - Sep 18, 2017

Ncardia Secures $60+ Million to Enhance and Expand Leading iPSC Offerings - Business Wire

Business Wire - Nov 16, 2021

Ncardia announces completion of €10.5M Investment Round - InnovationQuarter

InnovationQuarter - Nov 17, 2017

On back of Roche pact, newly formed Ncardia wins iPSC deal with Evotec - Fierce Biotech

Fierce Biotech - Dec 06, 2017

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment